https://k-115inhibitor.com/res....earch-developments-i
Medical biomarkers and targeted treatments for this disease remain elusive, therefore chemotherapy has been the standard of take care of early and metastatic TNBC. Our current conclusions put ErbB-2 in an unanticipated scenario the nucleus of TNBC (NErbB-2). Our research on ErbB-2 alternative splicing events, making use of a PCR-sequencing approach along with an RNA interference method, disclosed that TNBC cells present either the canonical (wild-type) ErbB-2, encoded by transc
Like
Comment
Share
